CSIMarket
 


Biodelivery Sciences International Inc   (BDSI)
Other Ticker:  
 
 

BDSI's Net Cash Flow Growth by Quarter and Year

Biodelivery Sciences International Inc 's Net Cash Flow results by quarter and year




BDSI Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 11.41 20.07 -5.66
III Quarter September - 9.17 -13.39 -6.24
II Quarter June - 20.40 15.89 43.63
I Quarter March 4.85 6.73 -2.49 -9.11
FY   4.85 47.71 20.08 22.62



BDSI Net Cash Flow first quarter 2021 Y/Y Growth Comment
Biodelivery Sciences International Inc reported fall in Net Cash Flow in the first quarter by -27.9% to $ 4.85 millions, from the same quarter in 2020.
The drop in the first quarter Biodelivery Sciences International Inc 's Net Cash Flow compares unfavorably to the Company's average Net Cash Flow growth of 2.65%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 55 other companies have achieved higher Net Cash Flow growth. While Biodelivery Sciences International Inc ' s Net Cash Flow drop of -27.9% ranks overall at the positon no. 869 in the first quarter.




BDSI Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -43.15 % - -
III Quarter September - - - -
II Quarter June - 28.38 % -63.58 % 1263.44 %
I Quarter March -27.9 % - - -
FY   - 137.6 % -11.23 % -

Financial Statements
Biodelivery Sciences International Inc 's first quarter 2021 Net Cash Flow $ 4.85 millions BDSI's Income Statement
Biodelivery Sciences International Inc 's first quarter 2020 Net Cash Flow $ 6.73 millions Quarterly BDSI's Income Statement
New: More BDSI's historic Net Cash Flow Growth >>


BDSI Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 24.43 % - -
III Quarter September - -55.05 % - -
II Quarter June - 203.12 % - -
I Quarter March -57.48 % -66.47 % - -
FY (Year on Year)   - 137.6 % -11.23 % -




Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #56
Healthcare Sector #163
Overall #869

Net Cash Flow Y/Y Growth Statistics
High Average Low
66.76 % 2.65 % -94.9 %
(Sep 30 2020)   (Jun 30 2019)
Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #56
Healthcare Sector #163
Overall #869
Net Cash Flow Y/Y Growth Statistics
High Average Low
66.76 % 2.65 % -94.9 %
(Sep 30 2020)   (Jun 30 2019)

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Biodelivery Sciences International Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
203.29 % -21.61 % -100 %
(Jun 30 2020)  


BDSI's I. Quarter Q/Q Net Cash Flow Comment
In the I. Quarter 2021 Biodelivery Sciences International Inc disclosed fall in Net Cash Flow from the previous quarter by -57.48% to $ 4.85 millions, from $ 11.41 millions achived in the previous quarter.

If you analyse current shortcoming at the I. Quarter, you should assume, that commonly I. Quarter 2021 results appear to be sluggish relative to the preciding period

Within Major Pharmaceutical Preparations industry 40 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Biodelivery Sciences International Inc 's Net Cash Flow growth quarter on quarter, overall rank is 549.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #41
Healthcare Sector #107
Overall #549
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #41
Healthcare Sector #107
Overall #549
Net Cash Flow Q/Q Growth Statistics
High Average Low
203.29 % -21.61 % -100 %
(Jun 30 2020)  


BDSI's I. Quarter Q/Q Net Cash Flow Comment
In the I. Quarter 2021 Biodelivery Sciences International Inc realized fall in Net Cash Flow sequentially by -57.48% to $ 4.85 millions, from $ 11.41 millions achived a quarter before.

This is not big issue, as I. Quarter Net Cash Flow generally seem to slow in the I. Quarter Gia Ravelli, market advisor told.

Within Major Pharmaceutical Preparations industry 40 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Biodelivery Sciences International Inc 's Net Cash Flow growth quarter on quarter, overall rank is 549.


Biodelivery Sciences International Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Cash Flow 12 Months Ending $ 45.82 $ 47.70 $ 56.36 $ 33.79 $ 29.28
Y / Y Net Cash Flow Growth (TTM) 56.48 % 137.7 % - 2166.53 % 0.15 %
Year on Year Net Cash Flow Growth Overall Ranking # 403 # 312 # 0 # 70 # 553
Seqeuential Net Cash Flow Change (TTM) -3.93 % -15.37 % 66.76 % 15.4 % 45.94 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 869 # 1052 # 483 # 795 # 157




Cumulative Net Cash Flow growth Comment
With the quarterly Net Cash Flow reported in the Mar 31 2021 period, Biodelivery Sciences International Inc 's cumulative twelve months Net Cash Flow were $ 46 millions, company would post below average annual Net Cash Flow growth of 45.94% year on year, if the fiscal year would end at Mar 31 2021.
A slow-down in the Biodelivery Sciences International Inc 's Net Cash Flow growth from the 11.41% growth in Dec 31 2020.

In the Healthcare sector 70 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 312 to 403.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
66.76 %
2.65 %
-94.9 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 56
Healthcare Sector # 71
Overall # 403

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
2166.53 %
333.9 %
-92.73 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 56
Sector # 163
S&P 500 # 869
Cumulative Net Cash Flow growth Comment
With the quarterly Net Cash Flow reported in the Mar 31 2021 period, Biodelivery Sciences International Inc 's cumulative twelve months Net Cash Flow were $ 46 millions, company would post below average annual Net Cash Flow growth of -92.73% year on year, if the fiscal year would end at Mar 31 2021.
A slow-down in the Biodelivery Sciences International Inc 's Net Cash Flow growth from the 11.41% growth in Dec 31 2020.

In the Healthcare sector 70 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 312 to 403.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
66.76 %
2.65 %
-94.9 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 56
Healthcare Sector # 71
Overall # 403

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
2166.53 %
333.9 %
-92.73 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 56
Sector # 163
S&P 500 # 869




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BDSI's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BDSI's Competitors
Net Cash Flow Growth for Biodelivery Sciences International Inc 's Suppliers
Net Cash Flow Growth for BDSI's Customers

You may also want to know
BDSI's Annual Growth Rates BDSI's Profitability Ratios BDSI's Asset Turnover Ratio BDSI's Dividend Growth
BDSI's Roe BDSI's Valuation Ratios BDSI's Financial Strength Ratios BDSI's Dividend Payout Ratio
BDSI's Roa BDSI's Inventory Turnover Ratio BDSI's Growth Rates BDSI's Dividend Comparisons



Companies with similar Net Cash Flow fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2021
Option Care Health Inc -0.89%$ -0.893 millions
Capricor Therapeutics Inc -1.12%$ -1.121 millions
Catalyst Biosciences Inc -4.20%$ -4.202 millions
Intra cellular Therapies Inc -4.67%$ -4.665 millions
Genprex Inc -6.30%$ -6.301 millions
Igm Biosciences Inc -7.14%$ -7.136 millions
Co diagnostics Inc -10.10%$ -10.099 millions
Alector Inc -14.79%$ -14.790 millions
Dynatronics Corp-18.25%$ -18.254 millions
Myriad Genetics Inc -19.85%$ -19.849 millions
Inogen Inc -22.01%$ -22.015 millions
Acelrx Pharmaceuticals Inc-22.96%$ -22.962 millions
Verrica Pharmaceuticals Inc -26.15%$ -26.147 millions
Aclaris Therapeutics Inc -26.87%$ -26.868 millions
Abiomed Inc -27.52%$ -27.521 millions
Biodelivery Sciences International Inc -27.85%$ -27.851 millions
Align Technology inc -28.90%$ -28.896 millions
Armata Pharmaceuticals Inc -29.15%$ -29.155 millions
United Therapeutics Corporation-31.58%$ -31.579 millions
Vertex Pharmaceuticals Inc-32.67%$ -32.667 millions
Syros Pharmaceuticals inc -35.91%$ -35.911 millions
Agenus Inc-35.92%$ -35.917 millions
Iradimed Corp-36.52%$ -36.522 millions
Assertio Holdings inc -36.98%$ -36.982 millions
Zymeworks Inc -37.89%$ -37.885 millions
Deciphera Pharmaceuticals Inc -39.86%$ -39.862 millions
Chiasma Inc -39.98%$ -39.980 millions
Nevro Corp -40.87%$ -40.865 millions
Xencor Inc-42.88%$ -42.880 millions
Vanda Pharmaceuticals Inc -44.17%$ -44.167 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NXGN's Profile

Stock Price

NXGN's Financials

Business Description

Fundamentals

Charts & Quotes

NXGN's News

Suppliers

NXGN's Competitors

Customers & Markets

Economic Indicators

NXGN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071